The pharmaceutical industry has yet to develop highly effective treatments for common chronic and neurological issues, like Alzheimer’s and cardiovascular disease. But GenAI promises to accelerate the discovery and development of breakthrough treatments. BCG’s Priya Chandran explores possible new approaches and how breakthrough drugs can be made more affordable and more available to the patients who need them. 

Learn More: 

Priya Chandran: https://on.bcg.com/3ZZO5ad 

BCG’s Latest Thinking on the Health Care Industry: https://on.bcg.com/4kFxhxH 

Biopharma Trends 2025: https://on.bcg.com/4mX6CxN 

 

This podcast uses the following third-party services for analysis:

Podtrac - https://analytics.podtrac.com/privacy-policy-gdrp